Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial

INTRODUCTION: The use of ketamine as an option in the treatment of depressive disorder is growing rapidly, supported by numerous clinical trials attesting its efficacy and safety. Esketamine, the S (+) enantiomer of ketamine, is the most widely used form in the anesthetic environment in some countri...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Correia-Melo, Fernanda S., Leal, Gustavo C., Carvalho, Michelle S., Jesus-Nunes, Ana Paula, Ferreira, Carolina B.N., Vieira, Flávia, Magnavita, Guilherme, Vale, Lucas A.S., Mello, Rodrigo P., Nakahira, Carolina, Argolo, Felipe C., Cardoso, Tanise, Souza, Cezar D.S., Fontes, Ana Teresa C., Ferreira, Marcelo B., Araújo-de-Freitas, Lucas, Tuena, Marco A., Echegaray, Mariana V.F., Cavalcanti, Diogo E., Lucchese, Ana C., Bandeira, Igor D., Telles, Manuela, Lima, Cássio S., Sampaio, Aline S., Silva, Samantha S., Marback, Roberta F., Del-Porto, José A., Abreu, José Neander, Sarin, Luciana M., Paixão, Camilla S., Carvalho, Lucas P., Machado, Paulo R.L., Turecki, Gustavo, Lacerda, Acioly L.T., Quarantini, Lucas C.
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160185/
https://ncbi.nlm.nih.gov/pubmed/30235716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012414
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires